Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™
Links shared publicly online about this topic.
- 236total visits
Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™
Biogen Idec (NASDAQ: BIIB) announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a sing
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Avonex, Biogen Idec
Most Recently Shared on June 7, 2011 at 1:10 pm By:
MedNewsToday: Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™: Biogen Idec (NASDAQ: BIIB)... http://bit.ly/lwswvh
Also Shared By:
Advertisement
MNT Multiple Scl
@mnt_multiplescl
Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™ http://mnt.to/3WRt #multiplesclerosis
1 year ago...